APA (7th ed.) Citation

Willey, C. D., Murphy, B. A., Netterville, J. L., Burkey, B. B., Shyr, Y., Shakhtour, B., . . . Cmelak, A. J. (2007). A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients. International Journal of Radiation Oncology, Biology, Physics, 67(5), 1323. https://doi.org/10.1016/j.ijrobp.2006.11.033

Chicago Style (17th ed.) Citation

Willey, Christopher D., et al. "A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients." International Journal of Radiation Oncology, Biology, Physics 67, no. 5 (2007): 1323. https://doi.org/10.1016/j.ijrobp.2006.11.033.

MLA (9th ed.) Citation

Willey, Christopher D., et al. "A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients." International Journal of Radiation Oncology, Biology, Physics, vol. 67, no. 5, 2007, p. 1323, https://doi.org/10.1016/j.ijrobp.2006.11.033.